Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

NCT00004930 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lung Cancer
Metastatic Cancer

Interventions

DRUG: doxorubicin hydrochloride

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]